Cognitive and nootropic peptides are researched for their effects on neurotrophic factor expression, synaptic plasticity, and neuroprotective pathways in preclinical models.
This category includes Selank, a synthetic tuftsin analogue studied for anxiolytic and cognitive-enhancing mechanisms; Semax, an ACTH(4-10) analogue investigated for BDNF upregulation and cerebrovascular research; Dihexa, a hexapeptide studied for its potent HGF/MET receptor system activation; and PE-22-28, explored for neurogenesis and memory-consolidation pathway research.
Additional compounds include FGL(L), Cerebrolysin peptide fragments, and SNAP-8 for specialised neuroscience research applications.
For laboratory and research use only. Not for human consumption.
